Bismuth-Cyclized Cell-Penetrating Peptides

Intracellular delivery of biological cargos, which would yield new research tools and novel therapeutics, remains an active area of research. A convenient and potentially general approach involves the conjugation of a cell-penetrating peptide to a cargo of interest. However, linear CPPs lack sufficient cytosolic entry efficiency and metabolic stability, while previous backbone cyclized CPPs have several drawbacks including the necessity for chemical synthesis and posttranslational conjugation to peptide/protein cargos and epimerization during cyclization. We report here a new class of bismuth cyclized CPPs with excellent cytosolic entry efficiencies, proteolytic stability, and potential compatibility with genetic encoding and recombinant production.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2024-09-03
DOI
https://doi.org/10.1021/acs.molpharmaceut.4c00688
Citations
11
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
2.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bismuth-Cyclized Cell-Penetrating Peptides

Dehua Pei, Jeremy L. Ritchey, Davis Ballard, Lindsi Filippi
11 citations
Molecular Pharmaceutics
RNA Interference and Gene Delivery
2.57
article

Bismuth-Cyclized Cell-Penetrating Peptides

Dehua Pei, Jeremy L. Ritchey, Davis Ballard, Lindsi Filippi
article en
11 citations

Abstract

Intracellular delivery of biological cargos, which would yield new research tools and novel therapeutics, remains an active area of research. A convenient and potentially general approach involves the conjugation of a cell-penetrating peptide to a cargo of interest. However, linear CPPs lack sufficient cytosolic entry efficiency and metabolic stability, while previous backbone cyclized CPPs have several drawbacks including the necessity for chemical synthesis and posttranslational conjugation to peptide/protein cargos and epimerization during cyclization. We report here a new class of bismuth cyclized CPPs with excellent cytosolic entry efficiencies, proteolytic stability, and potential compatibility with genetic encoding and recombinant production.

Molecular PharmaceuticsVol. 21(10)
The Ohio State University (US)
National Institutes of Health
Openalex Percentile: Top 10%
RNA Interference and Gene Delivery
2.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.